Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s stock price was up 12.1% during mid-day trading on Monday . The company traded as high as GBX 1.60 and last traded at GBX 1.57. Approximately 117,544 shares changed hands during trading, a decline of 74% from the average daily volume of 454,720 shares. The stock had previously closed at GBX 1.40.
Cizzle Biotechnology Trading Up 12.1%
The company has a market capitalization of £6.22 million, a P/E ratio of -4.90 and a beta of 0.38. The stock’s fifty day moving average is GBX 1.50 and its 200 day moving average is GBX 1.53.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Read More
- Five stocks we like better than Cizzle Biotechnology
- The gold chart Wall Street is terrified of…
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- This $15 Stock Could Go Down as the #1 Stock of 2026
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
